Cargando…

Cure of Hepatoblastoma Through Transcatheter Arterial Chemoembolization

Detalles Bibliográficos
Autores principales:	Yang, Tianyou, Yang, Jiliang, Tan, Tianbao, Pan, Jing, Hu, Chao, Li, Jiahao, Zou, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714075/ https://www.ncbi.nlm.nih.gov/pubmed/29226184 http://dx.doi.org/10.1177/2333794X17742750

Ejemplares similares

Clinical Application of Indocyanine Green Fluorescence Imaging in the Resection of Hepatoblastoma: A Single Institution's Experiences
por: Shen, Yuanchao, et al.
Publicado: (2022)

Association of CMYC polymorphisms with hepatoblastoma risk
por: Yang, Tianyou, et al.
Publicado: (2020)

The Many Presentations of Pneumomediastinum
por: Yang, Tianyou, et al.
Publicado: (2017)

NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children
por: Yang, Tianyou, et al.
Publicado: (2019)

Association of the TP53 rs1042522 C>G polymorphism and hepatoblastoma risk in Chinese children
por: Yang, Tianyou, et al.
Publicado: (2019)

LINC00673 rs11655237 C>T Polymorphism Impacts Hepatoblastoma Susceptibility in Chinese Children
por: Yang, Tianyou, et al.
Publicado: (2019)

Association between lncRNA‐H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population
por: Tan, Tianbao, et al.
Publicado: (2020)

Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis
por: Li, Jiahao, et al.
Publicado: (2020)

An effective approach for treating unresectable hepatoblastoma in infants and children: Pre-operative transcatheter arterial chemoembolization
por: ZHANG, JING, et al.
Publicado: (2013)

The impact of using three-dimensional printed liver models for patient education
por: Yang, Tianyou, et al.
Publicado: (2018)

Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman’s Disease
por: Hu, Chao, et al.
Publicado: (2020)

Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children
por: Jiang, Yizhou, et al.
Publicado: (2018)

The rs2147578 C > G polymorphism in the Inc-LAMC2–1:1 gene is associated with increased neuroblastoma risk in the Henan children
por: Yang, Tianyou, et al.
Publicado: (2018)

SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells
por: Zeng, Huijuan, et al.
Publicado: (2022)

TTF1 suppresses neuroblastoma growth and induces neuroblastoma differentiation by targeting TrkA and the miR-204/TrkB axis
por: Yang, Tianyou, et al.
Publicado: (2022)

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

Hepatic Artery Injection of (131)I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
por: Chen, Hui, et al.
Publicado: (2022)

Evaluation on Efficacy and Safety of Arsenic Trioxide Plus Transcatheter Arterial Chemoembolization Versus Transcatheter Arterial Chemoembolization alone for Unresectable Primary Liver Cancer
por: Yang, Haitao, et al.
Publicado: (2017)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Surgical Management of Hepatoblastoma and Recent Advances
por: Yang, Tianyou, et al.
Publicado: (2019)

Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
por: Zou, Jixue, et al.
Publicado: (2019)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2021)

The radiological prognostic factors of transcatheter arterial chemoembolization to hepatocellular carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2022)

Ruptured Hepatic Carcinoma After Transcatheter Arterial Chemoembolization()
por: Jia, Zhongzhi, et al.
Publicado: (2013)

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Nhu, Quan M, et al.
Publicado: (2016)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Pulmonary lipiodol embolism following transcatheter arterial chemoembolization
por: Moriya, Tomohiro, et al.
Publicado: (2020)

Polymicrobial bacteremia after treatment of transcatheter arterial chemoembolization: A case report
por: Fang, Xue-Yao, et al.
Publicado: (2019)

Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer
por: Sun, Jun-Hui, et al.
Publicado: (2017)

Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
por: Wei, Yanyan, et al.
Publicado: (2018)

Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone
por: Hassanin, Taha M, et al.
Publicado: (2021)

Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Study
por: Liu, Yao, et al.
Publicado: (2020)

Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
por: An, Chao, et al.
Publicado: (2021)

ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
por: Mao, Jiaren, et al.
Publicado: (2021)

Transcatheter arterial chemoembolization is safe and effective for patients with late-stage or recurrent oral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2022)

Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis
por: Liu, Xin, et al.
Publicado: (2023)

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer
por: Sun, Jun-Hui, et al.
Publicado: (2018)

Transcatheter Arterial Chemoembolization: History for More than 30 Years
por: Guan, Yong-Song, et al.
Publicado: (2012)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_plhh5o9i1fpcg31avpfs865u6c